Abstract
Objective
To compare the efficacies and side effects of Iodine-125 (125I) seeds implantation with afterloading radiotherapy on tumor xenografts derived from Hela cells.
Methods
Mice bearing Hela cells were randomly divided into three groups: two therapeutic groups receiving four 125I seeds implantation and afterloading therapy, respectively, and the one control group without any intervention. Comparisons were evaluated in aspects of curative efficacies (tumor volume, tumor inhibition rate and metastasis) and side effects (body weight, ovarian endocrine functions, skin lesion surrounding the tumor).
Results
The xenografts tumor volume of therapeutic groups were significantly smaller than that of controls(p < 0.05),both of the 125I seeds implantation and afterloading therapy showed excellent tumor inhibition rate. Furthermore, 125I seeds implantation had milder side effects on skin, weight loss, ovarian endocrine functions.
Conclusions
125I seed implantation may be an alternative minimally invasive therapy for cervical cancer.
Similar content being viewed by others
References
Carter J, Sonoda Y, Baser RE, Raviv L, Chi DS, Barakat RR, Iasonos A, Brown CL, Abu-Rustum NR (2010) A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecol Oncol 119:358–365. doi:10.1016/j.ygyno.2010.07.016
Serati M, Salvatore S, Uccella S, Laterza RM, Cromi A, Ghezzi F, Bolis P (2009) Sexual function after radical hysterectomy for early-stage cervical cancer: is there a difference between laparoscopy and laparotomy? J Sex Med 6:2516–2522. doi:10.1111/j.1743-6109.2009.01363.x
Brand AH, Bull CA, Cakir B (2006) Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer 16:288–293. doi:10.1111/j.1525-1438.2006.00348.x
Baalbergen A, Veenstra Y, Stalpers LL, Ansink AC (2010) Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev: CD006248. doi: 10.1002/14651858.CD006248.pub2
Henry AM, Al-Qaisieh B, Gould K, Bownes P, Smith J, Carey B, Bottomley D, Ash D (2010) Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience. Int J Radiat Oncol Biol Phys 76:50–56. doi:10.1016/j.ijrobp.2009.01.050
Takacsi-Nagy Z, Varga J, Poller I, Fodor J, Polgar C, Petranyi A, Major T, Nemeth G (2002) Successful treatment of a T1 cancer of the pancreatic head with high dose rate brachytherapy and external radiotherapy. Hepatogastroenterology 49:844–846
Zhongmin W, Yu L, Fenju L, Kemin C, Gang H (2010) Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Eur Radiol 20:1786–1791. doi:10.1007/s00330-009-1703-0
Peraud A, Goetz C, Siefert A, Tonn JC, Kreth FW (2007) Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: a pilot study. Childs Nerv Syst 23:39–46. doi:10.1007/s00381-006-0203-7
Huang K, Sneed PK, Kunwar S, Kragten A, Larson DA, Berger MS, Chan A, Pouliot J, McDermott MW (2009) Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol 91:83–93. doi:10.1007/s11060-008-9686-2
Stewart AJ, Mutyala S, Holloway CL, Colson YL, Devlin PM (2009) Intraoperative seed placement for thoracic malignancy—A review of technique, indications, and published literature. Brachytherapy 8:63–69. doi:10.1016/j.brachy.2008.09.002
Mutyala S, Stewart A, Khan AJ, Cormack RA, O’Farrell D, Sugarbaker D, Devlin PM (2010) Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. Int J Radiat Oncol Biol Phys 76:1114–1120. doi:10.1016/j.ijrobp.2009.02.067
Wang JJ, Yuan HS, Li JN, Jiang WJ, Jiang YL, Tian SQ (2009) Interstitial permanent implantation of 125I seeds as salvage therapy for re-recurrent rectal carcinoma. Int J Colorectal Dis 24:391–399. doi:10.1007/s00384-008-0628-4
Monk BJ, Tewari KS, Puthawala AA, Syed AM, Haugen JA, Burger RA (2002) Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation. Int J Radiat Oncol Biol Phys 52:806–815
Hinnen KA, Battermann JJ, van Roermund JG, Moerland MA, Jurgenliemk-Schulz IM, Frank SJ, van Vulpen M (2010) Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 76:1433–1438. doi:10.1016/j.ijrobp.2009.03.049
Wang J, Jiang Y, Li J, Tian S, Ran W, Xiu D (2009) Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma. J Exp Clin Cancer Res 28:88. doi:10.1186/1756-9966-28-88
Wang K, Jin Z, Du Y, Chen J, Zhan X, Wang L, Li Z, Zou D, Liu Y (2009) Evaluation of endoscopic-ultrasound-guided celiac ganglion irradiation with iodine-125 seeds: a pilot study in a porcine model. Endoscopy 41:346–351. doi:10.1055/s-0028-1119588
Conflict of interest statement
We declare that we have no conflict of interest in regards to this work.
Author information
Authors and Affiliations
Corresponding author
Additional information
H. Li and J. Zhao contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, Hx., Zhao, J., Shen, K. et al. Comparison of Iodine-125 seeds implantation and afterloading radiotherapy in murine models of human cervical cancer. Arch Gynecol Obstet 289, 1101–1106 (2014). https://doi.org/10.1007/s00404-013-3107-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-013-3107-2